Abstract
In this retrospective observational study, the addition of tranexamic acid (TXA) to blood component based resuscitation following combat injury showed improvement in measures of coagulopathy and survival, a benefit that was most prominent in those patients requiring massive transfusion.
Level of evidence: 2B